Healthcare & Life Sciences Insights
Discover Latham’s latest insights into the commercial, regulatory, and legal developments shaping the global healthcare and life sciences landscape.
Trending Topics
Featured Insights
Our Work
Renowned Trial Litigator David Marriott Joins Latham & Watkins
Latham Advises on Orchestra BioMed’s US$40 Million Public Offering
Recognition
Latham Ranks #1 M&A and Private Equity Law Firm Globally in H1 2025 League Tables
Firm’s M&A and Private Equity Practice earned top rankings across global, regional, and industry league tables, highlighting market leadership on the range of sophisticated transactions.
Litigator of the Week Runners-Up and Shout-Outs — Recor Medical
An intellectual property team secured the dismissal of counterclaims in a patent litigation case for their client Recor against market rival Medtronic
Latham Recognized With Six LMG Life Sciences EMEA Awards 2025
The firm and three lawyers were honored with major awards, including Deal of the Year and Lawyer of the Year.
The Book of Jargon® Series
Master Cell Bank
a storage facility for frozen tissue samples or Cell Lines held for research purposes and for surgical reconstruction of damaged body structures.
Epidemiology
the branch of science that deals with the incidence, distribution and control of disease or health-related states or events in a specific population.
Hyperkalemia
a medical term used to describe a potassium level in a patient’s blood that is higher than normal.
Overpayment
amounts that a person or entity receives or retains to which the person is not entitled. The ACA requires Medicare and Medicaid Providers, Suppliers, and other entities to report and return any overpayment of Medicare or Medicaid funds within 60 days of identifying the overpayment or face potential False Claims Act liability.
Sequestration
automatic, across the board budget cuts in the amount of US$1.2 trillion over nine years enacted as part of the Budget Control Act of 2011 that took effect in 2013 when Congress could not agree on a plan to reduce the deficit. Sequestration included aggregate reductions of Medicare payments to Providers at 2% per fiscal year.